rdf:type |
|
lifeskim:mentions |
umls-concept:C0009491,
umls-concept:C0010164,
umls-concept:C0028027,
umls-concept:C0030956,
umls-concept:C0033080,
umls-concept:C0034656,
umls-concept:C0040808,
umls-concept:C0040845,
umls-concept:C0301630,
umls-concept:C0633267,
umls-concept:C0814225,
umls-concept:C1514468,
umls-concept:C1579762,
umls-concept:C2587213,
umls-concept:C2729169
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-4-8
|
pubmed:abstractText |
Tretinoin is considered the benchmark prescription topical therapy for improving fine facial wrinkles, but skin tolerance issues can affect patient compliance. In contrast, cosmetic antiwrinkle products are well tolerated but are generally presumed to be less efficacious than tretinoin.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-11534915,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-12498532,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-16209160,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-17121065,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-17610656,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-18492135,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-18492182,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-18616783,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-20374602,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-2182354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-3045163,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-9382567,
http://linkedlifedata.com/resource/pubmed/commentcorrection/20374604-9744078
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1365-2133
|
pubmed:author |
pubmed-author:BertucciVV,
pubmed-author:FuJ J JJJ,
pubmed-author:GrimesP EPE,
pubmed-author:HillebrandG GGG,
pubmed-author:KaczvinskyJ RJR,
pubmed-author:MandyS HSH,
pubmed-author:MartinG WGW,
pubmed-author:OOIS KSK,
pubmed-author:PerezM IMI,
pubmed-author:RaleighPP,
pubmed-author:WeinkleS HSH
|
pubmed:issnType |
Electronic
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
647-54
|
pubmed:dateRevised |
2010-9-30
|
pubmed:meshHeading |
pubmed-meshheading:20374604-Administration, Topical,
pubmed-meshheading:20374604-Adult,
pubmed-meshheading:20374604-Aged,
pubmed-meshheading:20374604-Cosmetics,
pubmed-meshheading:20374604-Dermatologic Agents,
pubmed-meshheading:20374604-Emollients,
pubmed-meshheading:20374604-Face,
pubmed-meshheading:20374604-Female,
pubmed-meshheading:20374604-Humans,
pubmed-meshheading:20374604-Middle Aged,
pubmed-meshheading:20374604-Niacinamide,
pubmed-meshheading:20374604-Peptides,
pubmed-meshheading:20374604-Skin Aging,
pubmed-meshheading:20374604-Skin Care,
pubmed-meshheading:20374604-Treatment Outcome,
pubmed-meshheading:20374604-Tretinoin,
pubmed-meshheading:20374604-Vitamin A
|
pubmed:year |
2010
|
pubmed:articleTitle |
A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
|
pubmed:affiliation |
The Procter & Gamble Company, Cincinnati, OH 45241-9974, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|